Erratum: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (Eur. J. Haematol. (1995) 54 (281-287))
Publication
, Journal Article
Hussein, AM; Ross, M; Vredenburgh, J; Meisenberg, B; Hars, V; Gilbert, C; Petros, WP; Coniglio, D; Kurtzberg, J; Rubin, P; Peters, WP
Published in: European Journal of Haematology
January 1, 1995
Duke Scholars
Published In
European Journal of Haematology
ISSN
0902-4441
Publication Date
January 1, 1995
Volume
55
Issue
5
Start / End Page
347 / 356
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hussein, A. M., Ross, M., Vredenburgh, J., Meisenberg, B., Hars, V., Gilbert, C., … Peters, W. P. (1995). Erratum: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (Eur. J. Haematol. (1995) 54 (281-287)). European Journal of Haematology, 55(5), 347–356.
Hussein, A. M., M. Ross, J. Vredenburgh, B. Meisenberg, V. Hars, C. Gilbert, W. P. Petros, et al. “Erratum: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (Eur. J. Haematol. (1995) 54 (281-287)).” European Journal of Haematology 55, no. 5 (January 1, 1995): 347–56.
Hussein AM, Ross M, Vredenburgh J, Meisenberg B, Hars V, Gilbert C, et al. Erratum: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (Eur. J. Haematol. (1995) 54 (281-287)). European Journal of Haematology. 1995 Jan 1;55(5):347–56.
Hussein, A. M., et al. “Erratum: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (Eur. J. Haematol. (1995) 54 (281-287)).” European Journal of Haematology, vol. 55, no. 5, Jan. 1995, pp. 347–56.
Hussein AM, Ross M, Vredenburgh J, Meisenberg B, Hars V, Gilbert C, Petros WP, Coniglio D, Kurtzberg J, Rubin P, Peters WP. Erratum: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (Eur. J. Haematol. (1995) 54 (281-287)). European Journal of Haematology. 1995 Jan 1;55(5):347–356.
Published In
European Journal of Haematology
ISSN
0902-4441
Publication Date
January 1, 1995
Volume
55
Issue
5
Start / End Page
347 / 356
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology